Top Cryptocurrency Exchange Bybit Offers Up to 30% APY on Its New Liquidity Mining Pools

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 19 May 2022 – Bybit, a cryptocurrency with the second largest BTC Futures exchange by open interest, launched its new Liquidity Mining on May 19, 2022. Bybit users will have access to three liquidity pools: Bitcoin (BTC), Ether (ETH), and BitDAO (BIT), all paired with Tether (USDT). […]

DUBAI, UNITED ARAB EMIRATES – Media OutReach – 19 May 2022 – Bybit, a cryptocurrency with the second largest BTC Futures exchange by open interest, launched its new Liquidity Mining on May 19, 2022.

Bybit users will have access to three liquidity pools: Bitcoin (BTC), Ether (ETH), and BitDAO (BIT), all paired with Tether (USDT). The pools will allow users to deposit funds and earn up to 30% APY, with even higher rewards available when using up to 3x leverage.

Liquidity providers in all 160 countries where Bybit operates will be able to add one or both sides of the liquidity pair. The pool will automatically rebalance the assets and minimize the risk of impermanent loss. Liquidity providers will earn rewards in USDT that can be credited to their accounts or reinvested in the pool to increase rewards.

Bybit’s Liquidity Mining pools are based on a revamped automated market maker (AMM) model. Users can add liquidity to earn yield derived from trading fees. They can also add leverage to increase their share of the pool and maximize their yield. The liquidity pools will also allow Bybit users to swap between assets without needing to leave the platform and with minimal slippage.163275-Bybit.jpg

Our leverage feature allows users to access greater yields using their funds as collateral. Users can manage risks and safeguard themselves against excessive losses with multi-layered liquidation protocols to ensure safety and fairness across all Bybit trades, every step of the way.

We also have strategies to lock in profits and limit losses based on market movements, real prices that protect users against market manipulation, and an insurance fund that helps to protect traders from negative equity and significant losses beyond a trader’s position margin.

“We are very excited about the opportunities Bybit’s Liquidity Mining will open up for all Bybit users. As traders ourselves, we understand the importance of having a diversified trading and investment strategy optimized for earning passive income on your assets. To that end, our products offer some of the best yield-earning opportunities in the market today on one of the most reliable trading platforms out there. This marks another milestone in sharing growth opportunities with our community who believe in a future of DeFi and personal financial freedom,” said Ben Zhou, co-founder and CEO of Bybit.

Apart from an opportunity to gain returns with a low barrier to entry, one added benefit of liquidity mining is community building through trust. It incentivizes asset holders to be more involved in the community and play more active roles.

Bybit’s Liquidity Mining pools join other stellar products as part of their Bybit Earn range catering for investors of varied risk appetites. The range includes Dual Asset, which allows users to deposit their preferred asset and lock in an attractive yield; and Flexible Savings, which can serve investors as saving accounts for cryptocurrencies and feature safe, predictable yield payments.

About Bybit

Bybit is a cryptocurrency exchange established in March 2018 that offers a professional platform where crypto traders can find an ultra-fast matching engine, excellent customer service and multilingual community support. The company provides innovative online spot and derivatives trading services, mining and staking products, an NFT marketplace as well as API support, to retail and institutional clients around the world, and strives to be the most reliable exchange for the emerging digital asset class. Bybit is a proud partner of Formula One racing team, Oracle Red Bull Racing, esports teams NAVI, Astralis, Alliance, Virtus.pro and Oracle Red Bull Racing Esports, and association football (soccer) teams Borussia Dortmund and Avispa Fukuoka.

For media inquiries, please contact: press@bybit.com

For more information please visit: https://www.bybit.com/

For updates, please follow Bybit’s social media platforms on

https://discord.com/invite/bybit
https://www.facebook.com/Bybit
https://www.instagram.com/bybit_official/
https://www.linkedin.com/company/bybitexchange/
https://www.reddit.com/r/Bybit/
https://t.me/BybitEnglish
https://www.tiktok.com/@bybit_official
https://twitter.com/Bybit_Official
https://www.youtube.com/c/Bybit

#Bybit

Total
0
Shares
Previous Article

‫ Blackview تكشف النقاب عن خطة جديدة لتقديم الأجهزة الذكية القوية في منطقة الشرق الأوسط

Next Article

الاجتماع التاريخي يحث على إعطاء الأولوية للمياه والصرف الصحي لإعادة الصحة والمناخ والأهداف الاقتصادية إلى المسار الصحيح

Related Posts

‫محطة طاقة شمسية 800 ميجاوات في قطر تنشر وحدات LONGI متصلة بالشبكة

الدوحة، قطر، 21 أكتوبر 2022 / PRNewswire / — تم توصيل محطة طاقة شمسية بقدرة 800 ميجاوات في قطر بالشبكة بكامل طاقتها، مع جميع الوحدات المقدمة من LONGi . أقيم حفل إطلاق المشروع في قطر في 18 أكتوبر. وقد دُعيت شركة LONGI لحضور الحفل بصفتها الجهة الوحيدة التي تقدم خدمات المشروع. يقع مشروع الخرساء إلى الغرب […]

‫مولدات وحافلات مدعومة من Yuchai Engines ظهرت في أحداث كرة القدم المميزة في قطر

الدوحة، قطر، 7 دجنبر/كانون الأول 2022 / PRNewswire / — نظرًا لأن حدث كرة القدم المميز المرتقب ينظم منافساته الأكثر إثارة، فقد وصل أكثر من مليون مشجع إلى قطر. لمواجهة هذا التدفق الهائل من المشجعين، قامت الحكومة القطرية ببناء العديد من المجمعات السكنية ومرافق الترفيه، والتي يتم تشغيلها بواسطة 153 مجموعة من مولدات الطاقة Yuchai […]

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]